Literature DB >> 9892356

The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn.

T Hayashi1, H Umemori, M Mishina, T Yamamoto.   

Abstract

Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system. The ionotropic glutamate receptors are classified into two groups, NMDA (N-methyl-D-aspartate) receptors and AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate) receptors. The AMPA receptor is a ligand-gated cation channel that mediates the fast component of excitatory postsynaptic currents in the central nervous system. Here we report that AMPA receptors function not only as ion channels but also as cell-surface signal transducers by means of their interaction with the Src-family non-receptor protein tyrosine kinase Lyn. In the cerebellum, Lyn is physically associated with the AMPA receptor and is rapidly activated following stimulation of the receptor. Activation of Lyn is independent of Ca2+ and Na+ influx through AMPA receptors. As a result of activation of Lyn, the mitogen-activated protein kinase (MAPK) signalling pathway is activated, and the expression of brain-derived neurotrophic factor (BDNF) messenger RNA is increased in a Lyn-kinase-dependent manner. Thus, AMPA receptors generate intracellular signals from the cell surface to the nucleus through the Lyn-MAPK pathway, which may contribute to synaptic plasticity by regulating the expression of BDNF.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892356     DOI: 10.1038/16269

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  68 in total

Review 1.  Regulation of AMPA receptors by phosphorylation.

Authors:  A L Carvalho; C B Duarte; A P Carvalho
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Exploration of signal transduction pathways in cerebellar long-term depression by kinetic simulation.

Authors:  S Kuroda; N Schweighofer; M Kawato
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

3.  Delphilin: a novel PDZ and formin homology domain-containing protein that synaptically colocalizes and interacts with glutamate receptor delta 2 subunit.

Authors:  Yohei Miyagi; Tetsuji Yamashita; Masahiro Fukaya; Tomoko Sonoda; Toshiaki Okuno; Kazuyuki Yamada; Masahiko Watanabe; Yoji Nagashima; Ichiro Aoki; Kenji Okuda; Masayoshi Mishina; Susumu Kawamoto
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 4.  Regulation of AMPA receptor activity, synaptic targeting and recycling: role in synaptic plasticity.

Authors:  André R Gomes; Susana S Correia; Ana Luísa Carvalho; Carlos B Duarte
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

5.  Density-dependent changes of the pore properties of the P2X2 receptor channel.

Authors:  Yuichiro Fujiwara; Yoshihiro Kubo
Journal:  J Physiol       Date:  2004-04-23       Impact factor: 5.182

Review 6.  Neurotrophic effects of AMPA.

Authors:  Cristina Limatola
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

7.  AMPA receptor potentially participates in the mediation of the increased brain-derived neurotrophic factor following chronic ketamine use.

Authors:  Jianjun Yang; Zhiqiang Zhou; Chun Yang
Journal:  Psychopharmacology (Berl)       Date:  2011-10-19       Impact factor: 4.530

8.  Sensing muscle ischemia: coincident detection of acid and ATP via interplay of two ion channels.

Authors:  William T Birdsong; Leonardo Fierro; Frank G Williams; Valeria Spelta; Ligia A Naves; Michelle Knowles; Josephine Marsh-Haffner; John P Adelman; Wolfhard Almers; Robert P Elde; Edwin W McCleskey
Journal:  Neuron       Date:  2010-11-18       Impact factor: 17.173

Review 9.  Glutamate and the biology of gliomas.

Authors:  John de Groot; Harald Sontheimer
Journal:  Glia       Date:  2010-12-29       Impact factor: 7.452

10.  The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter.

Authors:  Ana M Carneiro; Susan L Ingram; Jean-Martin Beaulieu; Ava Sweeney; Susan G Amara; Sheila M Thomas; Marc G Caron; Gonzalo E Torres
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.